Wikipedia -WSS

Wikipedia

author：entertainment 2025-10-02 00:53:37 - browse：93

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Analysis of telehealth claims data suggest service duplication

WSS

Stroke deaths set to near 10 million globally by 2050

Was Amgen transparent enough on FDA's concern on cancer drug?

Readout Newsletter: Bayer study halts, Carmot to IPO, and more

A daunting task: navigating dual Medicare, Medicaid eligibility

Phenylephrine and the overlooked value of the placebo effect

VC firm General Catalyst wants to buy a health system

focus

Wikipedia

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Supreme Court strikes down use of affirmative action

David Sabatini, ex

Activists slam private health insurers over coverage restrictions

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Anesthesiologist group: stop taking Ozempic before surgery

When women are denied an abortion, their children fare worse than peers

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Wikipedia

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Why medical students are struggling with mental health

A virus, fished out of a lake, may have saved a man’s life

The future of health care in the House

PBM reforms clear House panel

PBM reforms clear House panel

focus

hotspot

focus

explore